45 results on '"Deschaseaux, C"'
Search Results
2. PSS5 COMPARING TWO TREAT-AND-EXTEND ANTI-VEGF REGIMENS FOR MANAGING WET AGE-RELATED MACULAR DEGENERATION - IMPLICATIONS FOR THE NATIONAL HEALTH SYSTEM IN FRANCE
3. PSY112 - FACTOR UTILIZATION ANALYSIS OF EXTENDED DURATION AND STANDARD-ACTING RECOMBINANT FVIII TREATMENTS FOR SEVERE HEMOPHILIA A IN SWEDEN
4. PSS38 - LITERATURE REVIEW OF ECONOMIC EVALUATIONS IN RETINAL CONDITIONS
5. PSS34 - COST-EFFECTIVENESS OF INTRAVITREAL AFLIBERCEPT VERSUS RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR EDEMA IN SPAIN
6. Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A
7. High-Sensitivity C-Reactive Protein Measurements in Patients with a History of Myocardial Infarction: A Targeted Literature Review
8. Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland
9. Burden of Illness in Patients with Elevated High-Sensitivity C-Reactive Protein Levels and a History of Myocardial Infarction: A Targeted Literature Review
10. Cost-Effectiveness of Sacubitril/ Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in The Czech Republic: Analysis Based on Patient Characteristics From Randomized Clinical Trial and Local Registries
11. Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy
12. PSY12 - Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A
13. A Systematic Literature Review On The Impact Of Therapeutic Interventions On Quality Of Life In Systolic Hf Randomized Clinical Trials
14. The Cost-Effectiveness Of Treatment For Chronic Heart Failure: A Systematic Review
15. A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction
16. Using The Clinical Summary Score From The Kansas City Cardiomyopathy Questionnaire As An Endpoint In Clinical Trials: Psychometric Support
17. Treatment Patterns Among Heart Failure Patients Within 30 Days Post Diagnosis: Results From A Us Claims Database Analysis
18. The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta-Analysis Comparing Pharmacological Treatments for Chronic Heart Failure
19. Health State Utilities In Chronic Heart Failure In The Uk
20. Real-World Health Care Resource Utilisation Among Patients With Chronic Heart Failure: A Canadian Assessment
21. PCV106 - Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland
22. PCV91 - Cost-Effectiveness of Sacubitril/ Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in The Czech Republic: Analysis Based on Patient Characteristics From Randomized Clinical Trial and Local Registries
23. PCV80 - Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy
24. PCV7 - Burden of Illness in Patients with Elevated High-Sensitivity C-Reactive Protein Levels and a History of Myocardial Infarction: A Targeted Literature Review
25. PCV33 - High-Sensitivity C-Reactive Protein Measurements in Patients with a History of Myocardial Infarction: A Targeted Literature Review
26. Costs of Acute Heart Failure in France
27. PCV12 Efficacy of Heart Failure Pharmacological Treatment Classes and Combinations: Network Meta-Analyses
28. PCV90 A Novel Conceptual Model of Caregiver Burden in Chronic Heart Failure: A Qualitative Study
29. PDB16 First Results of the Post-Marketing Survey of Vildagliptin in France
30. PCV118 - A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction
31. PCV101 - The Cost-Effectiveness Of Treatment For Chronic Heart Failure: A Systematic Review
32. PRM81 - Using The Clinical Summary Score From The Kansas City Cardiomyopathy Questionnaire As An Endpoint In Clinical Trials: Psychometric Support
33. PCN10 MALIGNANT GASTROINTESTINAL STROMAL TUMORS TREATED WITH IMATINIB IN FRANCE: EFFICACY IN REAL LIFE
34. PCN15 CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB IN FRANCE: EFFICACY IN REAL LIFE
35. PCV179 - Treatment Patterns Among Heart Failure Patients Within 30 Days Post Diagnosis: Results From A Us Claims Database Analysis
36. PCV118 - Health State Utilities In Chronic Heart Failure In The Uk
37. CV1 - The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta-Analysis Comparing Pharmacological Treatments for Chronic Heart Failure
38. PCV98 - Real-World Health Care Resource Utilisation Among Patients With Chronic Heart Failure: A Canadian Assessment
39. PCV57 - Costs of Acute Heart Failure in France
40. PCV144 - A Systematic Literature Review On The Impact Of Therapeutic Interventions On Quality Of Life In Systolic Hf Randomized Clinical Trials
41. PCV144 A Systematic Literature Review On The Impact Of Therapeutic Interventions On Quality Of Life In Systolic Hf Randomized Clinical Trials
42. PCV101 The Cost-Effectiveness Of Treatment For Chronic Heart Failure: A Systematic Review
43. PCV118 A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction
44. PCV118 Health State Utilities In Chronic Heart Failure In The Uk
45. PCV57 Costs of Acute Heart Failure in France
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.